Search

Showing total 226 results

Search Constraints

Start Over You searched for: Publication Year Range This year Remove constraint Publication Year Range: This year Journal alimentary pharmacology & therapeutics Remove constraint Journal: alimentary pharmacology & therapeutics Publisher wiley-blackwell Remove constraint Publisher: wiley-blackwell
226 results

Search Results

1. Systematic review: Clinical phenotypes, histopathological features and prognosis of enteropathy due to angiotensin II receptor blockers.

3. A Message from the Editors.

10. Letter: Shorter duration of intravenous terlipressin for variceal bleeding in patients with cirrhosis—A promising find. Author's reply.

11. Letter: Shorter duration of intravenous terlipressin for variceal bleeding in patients with cirrhosis—A promising find.

15. Editorial: Are glucagon‐like peptide‐1 receptor agonists the functional cure for patients with metabolic dysfunction‐associated cirrhosis?

17. Letter: The emerging role of novel capsule endoscopy systems in gastroenterology with specific reference to small bowel Crohn's disease. Authors' reply.

18. Editorial: Recompensation in PBC is good. But is it good enough? Authors' reply.

20. Letter: Use of liver stiffness measurement to identify liver cirrhosis in patients with chronic hepatitis D—Authors' reply.

21. Editorial: Diagnosis of GERD in patients with extra‐oesophageal symptoms—still a long way to go... Authors' reply'.

23. Letter: The emerging role of novel capsule endoscopy systems in gastroenterology with specific reference to small bowel Crohn's disease.

25. Letter: Diet‐microbiome interactions in inflammatory bowel disease—Navigating towards individualised dietary strategies.

27. Letter: Use of liver stiffness measurement to identify liver cirrhosis in patients with chronic hepatitis D.

34. Letter: Association of polymorphic variant of SerpinB3 and faster cirrhosis decompensation in patients with cirrhosis—More evidence needed. Authors' reply.

37. Editorial: Using machine learning to predict significant fibrosis in metabolic dysfunction‐associated steatotic liver disease—authors' reply.

39. Letter: Association of polymorphic variant of SerpinB3 and faster cirrhosis decompensation in patients with cirrhosis—More evidence needed.

45. Letter: Severe underweight and sarcopenia in decompensated cirrhosis are associated with high FGF21 levels—authors' reply.

46. Letter: Severe underweight and sarcopenia in decompensated cirrhosis are associated with high FGF21 levels.